SoylentNews is people
SoylentNews
El Reg reports:
Reported in The Lancet, the study [on paracetamol also known as acetaminophen] funded by the National Health and Medical Research Council of Australia and pharmaceutical company GlaxoSmithKline Australia ran for over three years and involved "a multicentre, double-dummy, randomised, placebo controlled trial across 235 primary care centres in Sydney."
The study saw some patients given regular doses paracetamol, others told to take the drug when in pain and a third group handed placebos. Those given paracetamol, in either mode, reported no less pain than those taking placebos. Nor did sugar-pill-poppers recover from their ailments more slowly.
The authors therefore "question the universal endorsement of paracetamol in this patient group."
In this interview the study's leader Professor Chris Maher even questions whether Paracetamol can be considered a pain-killer.
"The jury is out" on whether the drug lessens pain, Professor Maher says about two minutes into the interview.
So, what does work? Don't just lay there; for starters, get up and MOVE AROUND.
(Score: 2) by sjames on Friday July 25 2014, @10:06PM
Yes, it is. Too bad that's the FDA criterion for approval. Literally, they just have to show that it probably won't kill you and it's probably better than nothing. Note that this means there are cases where the drug may actually be inferior to snake oil.